Dopamine is a neurotransmitter that plays a critical role both peripherally and centrally in
vital functions such as cognition, reward, satiety, voluntary motor movements, pleasure, and …

Cystic fibrosis (CF) is a heritable, multiorgan disease that impacts all tissues that normally
express cystic fibrosis transmembrane conductance regulator (CFTR) protein. While the …

Background Elexacaftor/tezacaftor/ivacaftor (ETI) improves pulmonary disease in people
with cystic fibrosis (PwCF), but its effect on gastrointestinal symptoms, which also affect …

Objectives: The aim of the study was to review the evidence regarding the clinical use and
value of fecal calprotectin (FC) measurements in different gastrointestinal disorders in …

Cystic fibrosis (CF) is a genetic disease with mutational changes leading to profound
dysbiosis, both pulmonary and intestinal, from a very young age. This dysbiosis plays an …

The effects of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators
on lung function, pulmonary exacerbations, and quality of life have been well documented …

Abstract Background and Aims Cystic Fibrosis (CF) is associated with gut dysbiosis, local
and systemic inflammation, and impaired immune function. Gut microbiota dysbiosis results …

Highly effective CFTR modulator drug therapy is increasingly available to those with cystic
fibrosis. Multiple observational research studies are now being conducted to better …

Cystic fibrosis (CF), caused by biallelic inactivating mutations in the cystic fibrosis
transmembrane conductance regulator (CFTR) gene, has recently been categorized as a …

Abstract Background Elexacaftor-Tezacaftor-Ivacaftor (ETI) therapy is showing promising
efficacy for treatment of cystic fibrosis (CF) and is becoming more widely available since …